Postprandial Blood Sugar: What Happens After You Eat

Maine’s wild blueberries come off the barrens in August, and 99 percent of the crop goes straight into a freezer, which is how most of us eat them in February (University of Maine Cooperative Extension). What that bowl does to your blood over the following two hours has turned into a surprisingly loaded question. Postprandial blood sugar just means the glucose level in your blood after you eat. In a person without diabetes it climbs after a meal and is usually back near baseline by the two hour mark, which is why the standard oral glucose tolerance test reads at two hours and treats 139 mg/dL or below as normal. Continuous glucose monitor data from 153 healthy volunteers without diabetes found average glucose of 98 to 99 mg/dL and a median of only about 30 minutes a day spent above 140 mg/dL, so a short rise after eating is ordinary physiology rather than a warning sign.

What normal postprandial blood sugar looks like on paper

Eat something carbohydrate-heavy and glucose enters the bloodstream faster than your tissues can pull it out. Insulin rises, the tissues catch up, the level comes back down. In people without diabetes that whole arc is mostly finished inside two hours, which is exactly why the oral glucose tolerance test takes its reading there. On that test, given after a standardized glucose drink, the National Institute of Diabetes and Digestive and Kidney Diseases puts 139 mg/dL or below in the normal band, 140 to 199 mg/dL in the prediabetes band, and 200 mg/dL or above in the diabetes band. The matching fasting bands are 99 or below, 100 to 125, and 126 or above, and the A1C bands, reflecting roughly three months, are below 5.7 percent, 5.7 to 6.4 percent, and 6.5 percent or above.

Descriptive data on what non-diabetic glucose actually does across a full day came out of a 12-center prospective study that put a blinded Dexcom G6 on 153 healthy, non-obese people aged 7 to 80 for up to ten days. Mean average glucose landed at 98 to 99 mg/dL for every age group except those over 60, who averaged 104. Participants spent a median 96 percent of the time between 70 and 140 mg/dL, a median 2.1 percent of the day above 140 (about 30 minutes), and a median 1.1 percent below 70 (about 15 minutes). Within-individual variability averaged 17 percent.

Read those figures as a description of a small, screened, healthy group wearing one sensor model for a week and a half, because that is what the authors said they were. A benchmark for researchers designing studies. Not a scorecard for your Tuesday.

Diagnostic cut points and treatment targets are different animals

The number 140 travels a long way from where it started. It is a threshold on a standardized 75 gram glucose challenge, taken under controlled conditions, used to sort people into categories. It was never established as the point at which a sandwich starts doing damage to somebody without diabetes, and no research reviewed for this article sets any such threshold.

The other figures people quote at each other online come from somewhere different again. The American Diabetes Association’s suggested glucose targets for most nonpregnant adults with diabetes are an A1C below 7 percent, 80 to 130 mg/dL before meals, and less than 180 mg/dL measured one to two hours after a meal starts. Its continuous monitoring guidance sets a target range of 70 to 180 mg/dL with a goal of at least 70 percent of readings inside it, and says plainly that the people who benefit most from reviewing time in range data are those with type 1 diabetes and those with type 2 who use insulin and have tight glucose goals.

Those are treatment targets for people managing a diagnosed condition. Borrowing them as reference values for a body that does not have the condition is a category error, and the most common one in this whole conversation.

Why a sensor reading is not a blood reading

In March 2024 the FDA cleared the Dexcom Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, intended for anyone 18 years and older who does not use insulin. That covers people without diabetes who simply want to watch how diet and exercise move their numbers. The announcement carries two caveats worth holding onto: users should not make medical decisions based on the device’s output without talking to their healthcare provider, and the system is not meant for people with problematic hypoglycemia, because it is not designed to alert the user to that potentially dangerous condition.

A physical fact sits underneath every one of those readings, too. A sensor does not sample blood. It samples interstitial fluid in the tissue just under the skin, and glucose takes time to get there. A Mayo Clinic microdialysis study of six adults with type 1 diabetes, using a labeled tracer under clamped fasting conditions, found the median time for glucose to appear in abdominal subcutaneous interstitial space after an intravenous bolus was 6.8 minutes, with a range of 4.8 to 9.8 minutes. The curve on your phone is real. It is also a few minutes behind, and one compartment over.

Then there is the estimated A1C these apps like to display. A 2023 analysis of 153 children and adults without diabetes wearing a blinded sensor found the glucose management indicator, the CGM-derived estimate of HbA1c, ran on average 0.59 percent higher than their actual laboratory result, with a gap of 0.4 percent or more in 71 percent of them, against 39 percent in the cohort the formula was built from. The authors’ conclusion was blunt: the indicator does not accurately estimate HbA1c in healthy people without diabetes. If a wearable has told you your estimated A1C is drifting toward the prediabetes band, that is the finding to read first.

The same meal, two different curves

Part of what makes post-meal readings so easy to over-read is that they genuinely do differ between people, and the differences are not small. Researchers who continuously monitored a week of glucose in an 800-person cohort and logged responses to 46,898 meals found high variability in the response to identical meals, and concluded that universal dietary recommendations may have limited utility. Stanford researchers using the same tools found that even individuals considered normoglycemic by standard measures show high glucose variability on CGM, with levels reaching prediabetic ranges 15 percent of the time and diabetic ranges 2 percent of the time. They sorted the response patterns into categories they called glucotypes.

Those findings cut in both directions. They weaken the idea that one food ranking applies to everybody, and they equally weaken the idea that your neighbor’s flatter line after the same breakfast means you are doing something wrong. If you want a durable framework instead of a daily graph, eating patterns built around what northern New England actually grows is a better use of the attention.

The spike conversation is aimed at the wrong Mainers

The CDC estimates 40.1 million people in the United States have diagnosed or undiagnosed diabetes, roughly 12.0 percent of the population, and that 27.6 percent of adults who have it do not know, about 11.0 million people. Another 115.2 million US adults have prediabetes, including 31.3 million aged 65 or older, which is 52.1 percent of that age group.

Closer to home, the 2024 Behavioral Risk Factor Surveillance System recorded 11.5 percent of Maine adults and 10.1 percent of New Hampshire adults answering yes when asked whether a doctor had ever told them they have diabetes. Maine’s figure was 11.4 percent the year before. University of Maine Cooperative Extension, which runs the Dining with Diabetes Down East program, calls diabetes a large and rapidly growing public health problem for Maine and the United States, notes that Maine’s most northern and eastern counties tend to have the highest rates partly because their populations are older, and puts type 2 at approximately 90 percent of all cases.

The same survey carries some plainer numbers about what this region eats and does. In 2021, 13.1 percent of Maine adults consumed vegetables less than one time per day and 35.0 percent consumed fruit less than one time per day. New Hampshire’s figures that year were 15.3 percent and 35.7 percent. In 2024, 21.4 percent of Maine adults reported no physical activity at all in the past month, meaning 78.7 percent had done some. Those are the levers with real room in them, and finding them requires no hardware. A summer spent working out what is genuinely in season at Portland’s markets moves the first of those numbers further than a month of graphs will.

What the meal and movement studies actually tested

Three lines of research get quoted constantly in this space, almost always stripped of the population they were run in. They are worth restating with their people attached.

Food order first. A crossover pilot fed 11 adults with metformin-treated type 2 diabetes the same 628 calorie meal on two days a week apart, once with the carbohydrate eaten first and once with vegetables and protein first. Carbohydrate-last lowered blood glucose by 28.6 percent at 30 minutes, 37.0 percent at 60 minutes and 16.8 percent at 120 minutes, and the incremental area under the two hour curve was 73.5 percent lower. Eleven people, every one of them with diagnosed diabetes and on medication for it. Whether the same effect appears in someone without diabetes is not a question that study asked.

Walking after meals. A whole-room calorimeter crossover study put 10 inactive adults aged 60 or older, all with fasting glucose between 105 and 125 mg/dL, through three 15-minute treadmill bouts after meals, and compared that against a single sustained 45-minute walk. The post-meal pattern improved 24-hour glycemic control against a control day and beat the sustained walk at lowering three-hour post-dinner glucose. Ten people, supervised treadmill, older adults with impaired fasting glucose.

Breaking up sitting. A meta-analysis of seven acute one-day randomized crossover trials found that interrupting long stretches of sitting with frequent short bouts of light-intensity walking significantly reduced postprandial glucose and insulin compared with continued sitting, and outperformed standing breaks for both. Participants were mixed-sex adults, predominantly overweight or living with obesity. The paper reports standardized effect sizes rather than glucose units, so anyone quoting it to you in mg/dL has invented the figure.

None of that is a protocol, and none of it is offered as one. It describes what got measured, and in whom. What any of it means for your own week is a conversation with a clinician who can see your labs, particularly if you have reason to think something is off. The early signs of insulin resistance make a far more useful opening to that conversation than a screenshot of a peak.

What wearing one is actually proven to do

A systematic review and meta-analysis of 25 randomized controlled trials covering 2,996 participants found that CGM-based feedback reduced HbA1c by 0.28 percent and increased time in range by 7.4 percent, with non-significant effects on time above range, BMI and weight. The composition of that evidence base matters as much as the result. Seventeen of the 25 trials were in adults with type 2 diabetes, and only three studied people with obesity rather than diabetes. Eleven reported CGM-affiliated conflicts of interest, and only four evaluated whether the device changed what anybody ate. So the tool has a real track record in the population it was designed for, and a thin one everywhere else, where most of the interpretation is being done by the wearer.

Which brings it back to the blueberries. Maine’s crop grows on about 38,000 acres of commercial land managed by roughly 500 farmers across 480 farms, none of it planted, all of it native. It comes off in August and spends the rest of the year frozen, since fresh-market sales account for just 1 percent of production. Nobody needs a graph to know that eating it is fine. And if a number on a screen has genuinely worried you, the FDA’s own line about the first over-the-counter monitor is the one to follow: do not make medical decisions on the device’s output without talking to your healthcare provider. A lab draw and a conversation answer the question a sensor can only raise.

Sources

• National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Tests and Diagnosis. https://www.niddk.nih.gov/health-information/diabetes/overview/tests-diagnosis
• Shah VN, et al. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study. J Clin Endocrinol Metab 2019;104(10):4356-4364. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296129/
• Shah VN, Vigers T, Pyle L, Calhoun P, Bergenstal RM. Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes. Diabetes Technol Ther 2023;25(5):324-328. https://pubmed.ncbi.nlm.nih.gov/36790875/
• Hall H, Perelman D, Breschi A, et al. Glucotypes reveal new patterns of glucose dysregulation. PLOS Biology 2018;16(7):e2005143. https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.2005143
• Zeevi D, Korem T, Zmora N, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell 2015;163(5):1079-1094. https://pubmed.ncbi.nlm.nih.gov/26590418/
• US Food and Drug Administration. FDA Clears First Over-the-Counter Continuous Glucose Monitor. https://www.fda.gov/news-events/press-announcements/fda-clears-first-over-counter-continuous-glucose-monitor
• American Diabetes Association. Checking Your Blood Sugar. https://diabetes.org/living-with-diabetes/treatment-care/checking-your-blood-sugar
• American Diabetes Association. CGM and Time in Range. https://diabetes.org/about-diabetes/devices-technology/cgm-time-in-range
• Basu A, Dube S, Veettil S, et al. Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes. J Diabetes Sci Technol 2015;9(1):63-68. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495531/
• Richardson KM, Jospe MR, Bohlen LC, et al. The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes. Int J Behav Nutr Phys Act 2024;21(1):145. https://ijbnpa.biomedcentral.com/articles/10.1186/s12966-024-01692-6
• Shukla AP, Iliescu RG, Thomas CE, Aronne LJ. Food Order Has a Significant Impact on Postprandial Glucose and Insulin Levels. Diabetes Care 2015;38(7):e98-e99. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876745/
• DiPietro L, Gribok A, Stevens MS, Hamm LF, Rumpler W. Three 15-min bouts of moderate postmeal walking significantly improves 24-h glycemic control in older people at risk for impaired glucose tolerance. Diabetes Care 2013;36(10):3262-3268. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781561/
• Buffey AJ, Herring MP, Langley CK, Donnelly AE, Carson BP. The Acute Effects of Interrupting Prolonged Sitting Time in Adults with Standing and Light-Intensity Walking on Biomarkers of Cardiometabolic Health. Sports Medicine 2022;52(8):1765-1787. https://link.springer.com/article/10.1007/s40279-022-01649-4
• US Centers for Disease Control and Prevention. Diabetes Data and Research. https://www.cdc.gov/diabetes/php/data-research/index.html
• US Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System (BRFSS) Prevalence Data, 2011 to present. https://data.cdc.gov/Behavioral-Risk-Factors/Behavioral-Risk-Factor-Surveillance-System-BRFSS-P/dttw-5yxu
• University of Maine Cooperative Extension. Dining with Diabetes Down East. https://extension.umaine.edu/food-health/dining-with-diabetes/
• University of Maine Cooperative Extension. About the Maine Wild Blueberry. https://extension.umaine.edu/blueberries/about/

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making any health decisions.